XOMA to Announce First Quarter 2014 Financial Results and Host Webcast on May 7 Apr 30, 2014 1:25pm EDT
XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma Gangrenosum Apr 28, 2014 9:00am EDT
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results Mar 04, 2014 4:57pm EST
